I think the reformulations aren't going to be that

I think the reformulations aren't going to be that major an issue.

The topical creams for P dermatology applications should be no problem whatsoever, the sachets for B are already being produced, and the gel/foam for the anal application of B for sigmoidcolitis should be another no brainer.

As to the Kevetrin pill, that should be pretty far along as company had thought last summer they would be testing on healthy subjects around early 2018. BP has the knowledge of how to make capsules in many varying forms so I believe the pill(s) for BP and the GI tract applications will be accomplished in a timely manner.

IPIX still hitting on all cylinders and moving ahead as effectively as ever.
The lack of news regarding some items, though, lead me to believe that we may have BP cooperation for later trials and product development but that is just a WAG.

Spring is the time for things to bloom and I am sure IPIX will be a beauty once it starts blooming with positive news.

Dang, finished writing and posting this msg and then saw where Drano beat me to the punch.